The Global Health Consortium and FIU online have partnered with the Division of Arbovirus of the Pan American Health Organization (PAHO) to launch an exclusive, online course “Dengue Diagnosis and Clinical Management” (Diagnostico y Manejo Clinico del Dengue). The course, offered entirely in Spanish, will be located virtually at the Campus Library de Salud Publica, part of the PAHO website. The English course is coming soon!
Dengue is a mosquito-borne viral infection that affects infants, young children, and adults, with symptoms ranging from mild fever to incapacitating high fever, severe headache, pain behind the eyes, muscle and joint pain, and rash. The illness can evolve to severe dengue, characterized by shock, respiratory distress, severe bleeding, and/or serious organ impairment.
- 3.9 billion people are at risk of infection with dengue viruses
- Approximately 500 million people in the Americas are today at risk of dengue
- Dengue incidence has increased in the Americas over the past four decades, from 1.5 million cumulative cases in the 1980s to 16.2 million cumulative cases from 2010-2019
- Following infection with one serotype, subsequent infection with a different serotype increases a person's risk of severe dengue and death.
Today, severe dengue affects most Asian and Latin American countries and has become a leading cause of hospitalization and death among children and adults in these regions.